Mark Shearman Email

CEO . Aprinoia

,

Location

LinkedIn

Current Roles

Employees:
38
Revenue:
$5.9M
About
Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Our goal is to create novel products to meet critical patient needs, including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
Aprinoia Address
245 Main Street
null, null
Aprinoia Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.